Wolfgang Lederer1, Cristina Alomar Dominguez2, Marina Popovscaia3, Günther Putz2, Christian Humpel4. 1. Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: wolfgang.lederer@i-med.ac.at. 2. Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria. 3. Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Austria. 4. Psychiatric Laboratory, Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University of Innsbruck, Innsbruck, Austria.
Abstract
OBJECTIVES: During pregnancy various interactions occur between structural alterations of the maternal brain and placental metabolism. The aim of the present study was to investigate whether cerebrospinal fluid concentrations of tau and phospho-tau-181 protein vary during normal pregnancy and in women with preeclampsia and HELLP syndrome. STUDY DESIGN: We measured cerebrospinal fluid biomarkers, tau and phospho-tau-181 protein levels in 90 pregnant women electively assigned for regional anaesthesia during pregnancy or for cesarean section using enzyme-linked immunosorbent assays. RESULTS: Cerebrospinal fluid concentrations for tau and phospho-tau-181 in 66 women with normal pregnancy were 308.5±117.3pg/mL and 50.5±16.7pg/mL, respectively. Blood pressure, liver function, clotting activity and kidney function were significantly different in eleven women with preeclampsia and HELLP syndrome. The weight of the newly born (p<0.001; HR: 0.998), the weight of the placenta (p=0.018) and concentrations for phospho-tau-181 (p=0.043; HR: 1.211) correlated significantly with the disease. CONCLUSION: Mean concentrations of cerebrospinal fluid tau and phospho-tau-181 protein during pregnancy were evaluated. Phospho-tau-181 protein concentrations correlated with placental function supporting the hypothesis that altered expression of neuronal factors during pregnancy may affect development of the placenta.
OBJECTIVES: During pregnancy various interactions occur between structural alterations of the maternal brain and placental metabolism. The aim of the present study was to investigate whether cerebrospinal fluid concentrations of tau and phospho-tau-181 protein vary during normal pregnancy and in women with preeclampsia and HELLP syndrome. STUDY DESIGN: We measured cerebrospinal fluid biomarkers, tau and phospho-tau-181 protein levels in 90 pregnant women electively assigned for regional anaesthesia during pregnancy or for cesarean section using enzyme-linked immunosorbent assays. RESULTS: Cerebrospinal fluid concentrations for tau and phospho-tau-181 in 66 women with normal pregnancy were 308.5±117.3pg/mL and 50.5±16.7pg/mL, respectively. Blood pressure, liver function, clotting activity and kidney function were significantly different in eleven women with preeclampsia and HELLP syndrome. The weight of the newly born (p<0.001; HR: 0.998), the weight of the placenta (p=0.018) and concentrations for phospho-tau-181 (p=0.043; HR: 1.211) correlated significantly with the disease. CONCLUSION: Mean concentrations of cerebrospinal fluid tau and phospho-tau-181 protein during pregnancy were evaluated. Phospho-tau-181 protein concentrations correlated with placental function supporting the hypothesis that altered expression of neuronal factors during pregnancy may affect development of the placenta.
Authors: Malin Andersson; Jonatan Oras; Sven Egron Thörn; Ove Karlsson; Peter Kälebo; Henrik Zetterberg; Kaj Blennow; Lina Bergman Journal: PLoS One Date: 2021-02-08 Impact factor: 3.240
Authors: Lina Bergman; Henrik Zetterberg; Helena Kaihola; Henrik Hagberg; Kaj Blennow; Helena Åkerud Journal: PLoS One Date: 2018-05-02 Impact factor: 3.240
Authors: Cristina Alomar-Dominguez; L Dostal; J Thaler; G Putz; C Humpel; W Lederer Journal: Arch Womens Ment Health Date: 2020-10-02 Impact factor: 3.633